Global Prostate Cancer Treatment Market Size, Status and Forecast 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 94

Report ID: 15716

Prostate cancer is the most common cancer among men, the key risk factors for prostate cancer development is being old age, genetic, obesity and race.
In 2018, the global Prostate Cancer Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Prostate Cancer Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Prostate Cancer Treatment development in United States, Europe and China.

The key players covered in this study
Tolmar
Astellas Pharma
AstraZeneca
Ferring Pharmaceuticals
Johnson & Johnson
Abbott
Sanofi
Ipsen
Novartis
Bayer

Market segment by Type, the product can be split into
Biological Therapy
Chemotherapy

Market segment by Application, split into
Hospital
Research Institution
Clinic

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Prostate Cancer Treatment status, future forecast, growth opportunity, key market and key players.
To present the Prostate Cancer Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Prostate Cancer Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Prostate Cancer Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Biological Therapy
1.4.3 Chemotherapy
1.5 Market by Application
1.5.1 Global Prostate Cancer Treatment Market Share by Application (2014-2025)
1.5.2 Hospital
1.5.3 Research Institution
1.5.4 Clinic
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Prostate Cancer Treatment Market Size
2.2 Prostate Cancer Treatment Growth Trends by Regions
2.2.1 Prostate Cancer Treatment Market Size by Regions (2014-2025)
2.2.2 Prostate Cancer Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Prostate Cancer Treatment Market Size by Manufacturers
3.1.1 Global Prostate Cancer Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Prostate Cancer Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Prostate Cancer Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Prostate Cancer Treatment Key Players Head office and Area Served
3.3 Key Players Prostate Cancer Treatment Product/Solution/Service
3.4 Date of Enter into Prostate Cancer Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Prostate Cancer Treatment Market Size by Type (2014-2019)
4.2 Global Prostate Cancer Treatment Market Size by Application (2014-2019)

5 United States
5.1 United States Prostate Cancer Treatment Market Size (2014-2019)
5.2 Prostate Cancer Treatment Key Players in United States
5.3 United States Prostate Cancer Treatment Market Size by Type
5.4 United States Prostate Cancer Treatment Market Size by Application

6 Europe
6.1 Europe Prostate Cancer Treatment Market Size (2014-2019)
6.2 Prostate Cancer Treatment Key Players in Europe
6.3 Europe Prostate Cancer Treatment Market Size by Type
6.4 Europe Prostate Cancer Treatment Market Size by Application

7 China
7.1 China Prostate Cancer Treatment Market Size (2014-2019)
7.2 Prostate Cancer Treatment Key Players in China
7.3 China Prostate Cancer Treatment Market Size by Type
7.4 China Prostate Cancer Treatment Market Size by Application

8 Japan
8.1 Japan Prostate Cancer Treatment Market Size (2014-2019)
8.2 Prostate Cancer Treatment Key Players in Japan
8.3 Japan Prostate Cancer Treatment Market Size by Type
8.4 Japan Prostate Cancer Treatment Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Prostate Cancer Treatment Market Size (2014-2019)
9.2 Prostate Cancer Treatment Key Players in Southeast Asia
9.3 Southeast Asia Prostate Cancer Treatment Market Size by Type
9.4 Southeast Asia Prostate Cancer Treatment Market Size by Application

10 India
10.1 India Prostate Cancer Treatment Market Size (2014-2019)
10.2 Prostate Cancer Treatment Key Players in India
10.3 India Prostate Cancer Treatment Market Size by Type
10.4 India Prostate Cancer Treatment Market Size by Application

11 Central & South America
11.1 Central & South America Prostate Cancer Treatment Market Size (2014-2019)
11.2 Prostate Cancer Treatment Key Players in Central & South America
11.3 Central & South America Prostate Cancer Treatment Market Size by Type
11.4 Central & South America Prostate Cancer Treatment Market Size by Application

12 International Players Profiles
12.1 Tolmar
12.1.1 Tolmar Company Details
12.1.2 Company Description and Business Overview
12.1.3 Prostate Cancer Treatment Introduction
12.1.4 Tolmar Revenue in Prostate Cancer Treatment Business (2014-2019)
12.1.5 Tolmar Recent Development
12.2 Astellas Pharma
12.2.1 Astellas Pharma Company Details
12.2.2 Company Description and Business Overview
12.2.3 Prostate Cancer Treatment Introduction
12.2.4 Astellas Pharma Revenue in Prostate Cancer Treatment Business (2014-2019)
12.2.5 Astellas Pharma Recent Development
12.3 AstraZeneca
12.3.1 AstraZeneca Company Details
12.3.2 Company Description and Business Overview
12.3.3 Prostate Cancer Treatment Introduction
12.3.4 AstraZeneca Revenue in Prostate Cancer Treatment Business (2014-2019)
12.3.5 AstraZeneca Recent Development
12.4 Ferring Pharmaceuticals
12.4.1 Ferring Pharmaceuticals Company Details
12.4.2 Company Description and Business Overview
12.4.3 Prostate Cancer Treatment Introduction
12.4.4 Ferring Pharmaceuticals Revenue in Prostate Cancer Treatment Business (2014-2019)
12.4.5 Ferring Pharmaceuticals Recent Development
12.5 Johnson & Johnson
12.5.1 Johnson & Johnson Company Details
12.5.2 Company Description and Business Overview
12.5.3 Prostate Cancer Treatment Introduction
12.5.4 Johnson & Johnson Revenue in Prostate Cancer Treatment Business (2014-2019)
12.5.5 Johnson & Johnson Recent Development
12.6 Abbott
12.6.1 Abbott Company Details
12.6.2 Company Description and Business Overview
12.6.3 Prostate Cancer Treatment Introduction
12.6.4 Abbott Revenue in Prostate Cancer Treatment Business (2014-2019)
12.6.5 Abbott Recent Development
12.7 Sanofi
12.7.1 Sanofi Company Details
12.7.2 Company Description and Business Overview
12.7.3 Prostate Cancer Treatment Introduction
12.7.4 Sanofi Revenue in Prostate Cancer Treatment Business (2014-2019)
12.7.5 Sanofi Recent Development
12.8 Ipsen
12.8.1 Ipsen Company Details
12.8.2 Company Description and Business Overview
12.8.3 Prostate Cancer Treatment Introduction
12.8.4 Ipsen Revenue in Prostate Cancer Treatment Business (2014-2019)
12.8.5 Ipsen Recent Development
12.9 Novartis
12.9.1 Novartis Company Details
12.9.2 Company Description and Business Overview
12.9.3 Prostate Cancer Treatment Introduction
12.9.4 Novartis Revenue in Prostate Cancer Treatment Business (2014-2019)
12.9.5 Novartis Recent Development
12.10 Bayer
12.10.1 Bayer Company Details
12.10.2 Company Description and Business Overview
12.10.3 Prostate Cancer Treatment Introduction
12.10.4 Bayer Revenue in Prostate Cancer Treatment Business (2014-2019)
12.10.5 Bayer Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details